Vinorelbine (VRB) plus gemcitabine (GEM) as first-line treatment for elderly patients (p) with advanced non-small cell lung cancer (NSCLC): Molecular correlates

被引：0
|
作者：
Maestu, I.
Isla, D.
Diz, P.
Munoz, J.
Oramas, J.
Garcia, R.
del Barco, S.
Provencio, M.
Taron, M.
Rosell, R.
机构：
[1] Hosp Virgen de los Lirios, Alcoy, Spain
[2] Hosp Clin Univ Lozano Blesa, Zaragoza, Spain
[3] Complejo Hosp Leon, Leon, Spain
[4] Hosp Univ Dr Peset, Valencia, Spain
[5] Hosp Univ Tenerife, San Cristobal la Laguna, Spain
[6] Hosp Univ Gregorio Maranon, Madrid, Spain
[7] Hosp Josep Trueta, Girona, Spain
[8] Hosp Puerta de Hierro, Madrid, Spain
[9] Hosp Badalona Germans Trias & Pujol, Badalona, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
18040
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Gemcitabine and vinorelbine in advanced non-small cell lung cancer
    Vazquez, F
    Cueva, JF
    Baron, FJ
    Candamio, S
    Calvo, M
    Irigoyen, A
    Huidobro, C
    Lopez, R
    ANNALS OF ONCOLOGY, 1998, 9 : 103 - 103
  • [42] Gemcitabine in the treatment of elderly patients with advanced non-small cell lung cancer
    Shepherd, FA
    Abratt, RP
    Anderson, H
    Gatzemeier, U
    Anglin, G
    Iglesias, J
    SEMINARS IN ONCOLOGY, 1997, 24 (02) : S50 - S55
  • [43] Phase mi study of Gemcitabine plus vinorelbine in non-small cell lung cancer (NSCLC)
    Puertas, J
    Esteban, E
    Fra, J
    Liano, JLG
    Vieitez, JM
    Estrada, E
    Palacio, I
    Muniz, I
    Buesa, JM
    Lacave, AJ
    ANNALS OF ONCOLOGY, 1998, 9 : 99 - 99
  • [44] Phase II Randomized Study of Vandetanib Plus Gemcitabine or Gemcitabine Plus Placebo as First-Line Treatment of Advanced Non-Small-Cell Lung Cancer in Elderly Patients
    Gridelli, Cesare
    Novello, Silvia
    Zilembo, Nicoletta
    Luciani, Andrea
    Favaretto, Adolfo Gino
    De Marinis, Filippo
    Genestreti, Giovenzio
    Crino, Lucio
    Grossi, Francesco
    Caffo, Orazio
    Ferrau, Francesco
    Cruciani, Giorgio
    Brandes, Alba Ariela
    Galetta, Domenico
    Barni, Sandro
    Fasola, Gianpiero
    Cerea, Giulio
    Ferrari, Silvia
    Iannacone, Claudio
    Ciardiello, Fortunato
    JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (05) : 733 - 737
  • [45] Vinorelbine, ifosfamide and cisplatin as first-line treatment in patients with inoperable non-small cell lung cancer
    Montalar, J
    Morales, S
    Maestu, I
    Camps, C
    Vadell, C
    García, R
    Yuste, AL
    Torregrosa, D
    Segura, A
    LUNG CANCER, 2001, 34 (02) : 305 - 311
  • [46] Phase II study of erlotinib plus gemcitabine in first-line treatment of poor prognosis, advanced non-small cell lung cancer patients
    Grigorescu, A. C.
    Bala, C.
    JOURNAL OF BUON, 2013, 18 (01): : 188 - 194
  • [47] Gemcitabine/vinorelbine/cisplatin in patients with advanced non-small cell lung cancer
    Doweik, L
    Pohl, G
    Malayeri, R
    Krajnik, G
    Minar, W
    Pirker, R
    8TH CENTRAL EUROPEAN LUNG CANCER CONFERENCE, 2002, : 263 - 266
  • [48] PROSPECTIVE PHASE II TRIAL OF A COMBINATION OF GEMCITABINE AND UFT AS FIRST-LINE TREATMENT IN ELDERLY PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER
    Baek, J. H.
    Kim, H.
    Kim, H. J.
    Park, J.
    Min, Y. J.
    ANNALS OF ONCOLOGY, 2010, 21 : 157 - 157
  • [49] Cisplatin plus vinorelbine or gemcitabine in patients with advanced non-small cell lung cancer: Pharmacoeconomic considerations
    Hughes, DA
    EUROPEAN JOURNAL OF CANCER, 2005, 41 (11) : 1655 - 1655
  • [50] Prospective Phase II Trial of a Combination of Gemcitabine and UFT as First-line Treatment in Elderly Patients With Advanced Non-small Cell Lung Cancer
    Baek, J.
    Ahn, J.
    Jegal, Y.
    Park, C.
    Lee, Y.
    Cha, H.
    Kwon, W.
    Noh, Y.
    Park, J.
    Min, Y.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S621 - S621
12345